A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor
Clinical trial NCT04444895 · COMPLETED
Trial details
- NCT number
- NCT04444895
- Sponsor
- Shire
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-05
- Primary completion
- 2023-05-05
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.